BCA
SANA icon

Bay Colony Advisors’s Sana Biotechnology SANA Stock Holding History

Bay Colony Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1K Sell
11,500
-4,250
-27% -$13.7K ﹤0.01% 490
2026
Q1 		$45.4K Hold
15,750
– – 0.01% 485
2025
Q4 		$64.1K Buy
15,750
+4,750
+43% +$21.3K 0.01% 495
2025
Q3 		$39K Buy
+11,000
New +$39.8K ﹤0.01% 508
2024
Q2 		– Sell
-13,650
Closed -$137K – 449
2024
Q1 		$137K Buy
+13,650
New +$102K 0.02% 385

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Bay Colony Advisors's SANA Position: Q2 2026 in Review

Bay Colony Advisors reduced its Sana Biotechnology (SANA) stake by 27% in Q2 2026, selling an estimated $13.7K and leaving 11,500 shares worth $40.1K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Bay Colony Advisors first reported a position in SANA in Q1 2024 and has held it in 5 quarters since. The position peaked at $137K in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Bay Colony Advisors held 11,500 shares of Sana Biotechnology worth $40.1K as of Q2 2026.
  • Bay Colony Advisors sold 4,250 Sana Biotechnology shares in Q2 2026, an estimated $13.7K.
  • Sana Biotechnology made up ﹤0.01% of Bay Colony Advisors's portfolio in Q2 2026, its #490 holding.
  • Bay Colony Advisors first reported a position in Sana Biotechnology in Q1 2024 and has held it in 5 quarters since.
  • Bay Colony Advisors's Sana Biotechnology position peaked at $137K in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.